Kura Oncology KURA Insider Ownership

NASDAQ KURA
$13.15 +0.00 (+0.00%)
As of: Sep 4, 2026 · 2:27 PM EDT

Insider Holdings by Owner

1.61Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
0.027%
0% pp QoQ
Shares Held by Insiders
23.98K
filed for Sep 2026
0.00% QoQ
Shares Outstanding
87.65Mn
87,645,000 shares
Direct Holdings
23.98K
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
12
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

Kura Oncology's top three insider shareholders as of August 29, 2026 are Troy Edward Wilson (President And Ceo, 479.19K shares), Troy Edward Wilson (President And Ceo, 435.46K shares), Troy Edward Wilson (President And Ceo, 379.19K shares).

Form 4 Holdings

Insiders Holding KURA

Insiders 12
Shares held 1.61Mn
Of outstanding 1.84%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Troy Edward Wilson President And Ceo 0 479,194 479,194 29.7% 24 Aug, 2026
2 Teresa Brophy Bair Chief Legal Officer 195,444 0 195,444 12.1% 21 Aug, 2026
3 Mollie Leoni Chief Medical Officer 182,345 0 182,345 11.3% 22 Jun, 2026
4 Brian T. Powl Chief Commercial Officer 169,269 0 169,269 10.5% 24 Aug, 2026
5 Kathleen Ford Chief Operating Officer 153,560 0 153,560 9.5% 20 May, 2026
6 Thomas Malley Director 10,000 139,557 149,557 9.3% 19 Mar, 2026
7 Thomas James Doyle Svp, Finance Accounting 145,167 0 145,167 9.0% 27 Jan, 2026
8 Stephen Dale Chief Medical Officer 38,817 0 38,817 2.4% 31 Jan, 2024
9 Francis Burrows Chief Scientific Officer 32,424 0 32,424 2.0% 27 Jan, 2026
10 Faheem Hasnain Director 23,983 0 23,983 1.5% 10 Dec, 2025
11 Marc Grasso Cfo, Cbo 21,900 0 21,900 1.4% 28 Jan, 2022
12 Kirsten Flowers Cco Chief Strategy Officer 20,605 0 20,605 1.3% 31 Jan, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

448 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
24 Aug, 2026 Troy Edward Wilson President And Ceo Acquired P 100,000 $12.39 $1.24Mn 479,194 Indirect
21 Aug, 2026 Brian T. Powl Chief Commercial Officer Disposed S 4,345 $11.89 $51.66K 169,269 Direct
19 Aug, 2026 Teresa Brophy Bair Chief Legal Officer Disposed S 31,487 $12.63 $397.68K 195,444 Direct
17 Aug, 2026 Troy Edward Wilson President And Ceo Acquired P 100,000 $11.12 $1.11Mn 379,194 Indirect
18 Jun, 2026 Mollie Leoni Chief Medical Officer Disposed S 84,929 $9.82 $834.28K 182,345 Direct
04 Jun, 2026 Faheem Hasnain Director Acquired A 35,000 $0.00 $0 35,000 Direct
04 Jun, 2026 Helen Louise Collins Director Acquired A 35,000 $0.00 $0 35,000 Direct
04 Jun, 2026 Thomas Malley Director Acquired A 35,000 $0.00 $0 35,000 Direct
04 Jun, 2026 Diane L. Parks Director Acquired A 35,000 $0.00 $0 35,000 Direct
04 Jun, 2026 Carol Schafer Director Acquired A 35,000 $0.00 $0 35,000 Direct
04 Jun, 2026 Michael Vasconcelles Director Acquired A 35,000 $0.00 $0 35,000 Direct
21 May, 2026 Brian T. Powl Chief Commercial Officer Disposed S 10,000 $11.00 $110.00K 173,614 Direct
19 May, 2026 Brian T. Powl Chief Commercial Officer Disposed S 339 $9.21 $3.12K 183,614 Direct
18 May, 2026 Teresa Brophy Bair Chief Legal Officer Disposed S 2,256 $9.38 $21.16K 226,931 Direct
19 May, 2026 Kathleen Ford Chief Operating Officer Disposed S 2,257 $9.08 $20.48K 153,560 Direct
23 Mar, 2026 Troy Edward Wilson President And Ceo Acquired M 6,103 $6.15 $37.53K 435,456 Direct
23 Mar, 2026 Troy Edward Wilson President And Ceo Acquired M 6,103 $0.00 $0 0 Direct
18 Mar, 2026 Thomas Malley Director Acquired M 10,000 $3.12 $31.20K 10,000 Direct
18 Mar, 2026 Thomas Malley Director Acquired M 10,000 $0.00 $0 0 Direct
27 Jan, 2026 Francis Burrows Chief Scientific Officer Disposed S 1,311 $8.46 $11.09K 32,424 Direct